This discussion will address the Yates Memorandum, which emphasizes the US Department of Justice’s intent to hold individuals more accountable for organizational misconduct. We will talk about its implications and potential impact on global companies, particularly in the life sciences and healthcare industries. The discussion will address the recent Warner indictment as an example of Yates Memorandum enforcement in practice and provide recommendations on best practices to avoid such risks.
Members-only access
To access the full resource, you must be a
member.
Already a member?
Login to unlock.
Login
Not an ACC member?
Gain access to a comprehensive collection of global
resources for in-house counsel
Sign
up for a 30-day trial
The information in any resource collected in this virtual library should
not be construed as legal advice or legal opinion on specific facts and should not be considered representative of the views of its authors, its sponsors, and/or ACC. These resources are not intended as a definitive statement on the subject addressed. Rather, they are intended to serve as a tool providing practical advice and references for the busy in-house practitioner and other readers.